COM:EDITASMEDICINE
Editas Medicine
- Stock
Last Close
2.37
22/11 21:00
Market Cap
417.77M
Beta: -
Volume Today
2.25M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 390K - | 1.22M 213.08% | 1.76M 44.39% | 2.39M 35.62% | 1.46M 38.98% | -54.83M 3,858.19% | -114.87M 109.49% | -106.58M 7.21% | -46.55M 56.33% | |||
average payables | 1.50M - | 1.99M 32.58% | 3.01M 51.43% | 4.33M 43.83% | 4.67M 7.93% | 5.58M 19.50% | 6.13M 9.68% | 5.73M 6.47% | 7.28M 27.08% | 8.89M 22.11% | ||
average receivables | 509.50K - | 553.50K 8.64% | 383.50K 30.71% | 354.50K 7.56% | 224K 36.81% | 3.23M 1,343.30% | 3.16M 2.34% | 2.71M 14.30% | 7.67M 183.30% | |||
book value per share | -0.99 - | -2.33 135.08% | 4.18 279.45% | 5.16 23.52% | 5.01 2.83% | 5.25 4.71% | 6.72 27.90% | 8.19 21.92% | 5.25 35.85% | 0.00 99.91% | ||
capex per share | -0.08 - | -0.04 49.14% | -0.11 170.46% | -0.05 52.90% | -0.10 97.68% | -0.12 22.23% | -0.12 0.96% | -0.12 3.46% | -0.06 49.16% | -0.00 99.90% | ||
capex to depreciation | -7.75 - | -3.04 60.81% | -2.91 4.35% | -0.77 73.59% | -1.46 90.37% | -2.18 49.16% | -1.81 16.98% | -1.58 12.73% | -0.65 58.84% | -3.80 485.16% | ||
capex to operating cash flow | 0.14 - | 0.26 88.36% | 0.07 73.58% | 0.22 212.52% | 0.10 52.43% | 0.15 45.79% | 0.04 73.74% | 0.05 22.29% | 0.02 52.32% | 0.04 53.76% | ||
capex to revenue | -0.88 - | -0.58 34.31% | -0.15 74.01% | -0.15 0.75% | -0.30 101.79% | -0.08 73.72% | -0.31 295.62% | -0.21 33.10% | ||||
cash per share | 0.69 - | 4.01 482.96% | 5.75 43.41% | 8.16 41.91% | 7.83 4.03% | 9.15 16.75% | 6.86 24.98% | 7.39 7.74% | 5.01 32.17% | 0.00 99.92% | ||
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 228.32 - | 5.31 97.68% | 18.05 240.21% | 0.34 98.10% | 7.43 2,067.40% | 24.33 227.40% | 3.82 84.32% | 95.27 2,397.08% | ||||
debt to assets | 0.85 - | 0.03 96.04% | 1.34 3,869.11% | 0.20 85.30% | 0.11 44.27% | 0.11 1.88% | 0.06 46.89% | 0.05 20.13% | 0.04 14.70% | 0.09 119.45% | 0.07 14.34% | |
debt to equity | -1.20 - | -0.03 97.76% | -2.41 8,849.39% | 0.34 113.93% | 0.20 41.28% | 0.19 2.64% | 0.11 42.14% | 0.07 40.08% | 0.05 28.25% | 0.12 155.73% | 0.10 14.10% | |
dividend yield | 0.22 - | 0.00 99.32% | 0.00 99.41% | 0.00 57.95% | ||||||||
earnings yield | -0.05 - | -0.11 130.40% | -0.19 65.64% | -0.10 47.75% | -0.10 5.68% | -0.08 18.71% | -0.03 68.08% | -0.10 287.23% | -0.34 225.41% | -0.00 99.94% | ||
enterprise value | 99K - | 270.81M 273,443.80% | 706.47M 160.87% | 372.70M 47.24% | 1.13B 202.11% | 969.11M 13.93% | 1.27B 31.14% | 4.00B 214.39% | 1.62B 59.50% | 511.48M 68.39% | 769.44B 150,334.68% | |
enterprise value over ebitda | -20.07 - | -9.71 51.62% | -3.83 60.53% | -9.43 146.16% | -8.55 9.42% | -9.01 5.43% | -29.63 228.89% | -8.38 71.73% | -2.26 72.98% | -5.02K 221,744.00% | ||
ev to operating cash flow | -31.29 - | -130.75 317.89% | -7.47 94.29% | -119.57 1,501.67% | -21.20 82.27% | -31.25 47.39% | -22.22 28.91% | -9.88 55.54% | -2.88 70.81% | -5.82K 201,744.78% | ||
ev to sales | 433.68 - | 61.57 85.80% | 82.02 33.21% | 30.34 63.00% | 61.90 104.00% | 44.04 28.86% | 63.35 43.85% | 25.95 59.04% | ||||
free cash flow per share | -0.64 - | -0.19 70.06% | -1.66 766.09% | -0.28 82.83% | -1.07 276.47% | -0.94 12.54% | -3.19 240.51% | -2.54 20.38% | -2.64 4.03% | -0.00 99.93% | ||
free cash flow yield | -0.04 - | -0.01 70.06% | -0.10 871.21% | -0.01 90.93% | -0.05 408.52% | -0.03 32.80% | -0.05 43.81% | -0.10 110.25% | -0.30 211.39% | -0.00 99.94% | ||
graham net net | -1.09 - | -2.47 126.16% | 2.84 215.20% | 4.10 44.21% | 3.95 3.61% | 4.22 6.77% | 2.95 30.16% | 4.68 58.59% | 2.15 53.92% | 0.00 99.89% | ||
graham number | 4.44 - | 10.34 132.73% | 16.84 62.81% | 18.61 10.54% | 16.23 12.81% | 17.08 5.26% | 16.79 1.68% | 22.46 33.71% | 18.75 16.49% | 0.01 99.92% | ||
income quality | 0.63 - | 0.07 88.28% | 0.51 593.15% | 0.08 84.77% | 0.42 431.14% | 0.30 26.85% | 1.55 409.97% | 0.85 45.13% | 0.80 5.45% | 0.86 7.22% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -374.21 - | -246.94 34.01% | 1.57K 734.80% | -122.63 107.82% | 33.01 126.92% | 19.27 41.63% | -53.48 - | |||||
interest debt per share | 0.03 - | 5.60 19,344.63% | 1.40 75.06% | 1.04 25.64% | 0.89 14.64% | 0.44 50.91% | 0.45 2.39% | 0.39 12.52% | 0.70 79.84% | 0.00 99.93% | ||
inventory turnover | ||||||||||||
invested capital | -1.20 - | -0.03 97.76% | -2.41 8,849.39% | 0.34 113.93% | 0.20 41.28% | 0.19 2.64% | 0.11 42.14% | 0.07 40.08% | 0.05 28.25% | 0.12 155.73% | 0.10 14.10% | |
market cap | 281.02M - | 649.73M 131.20% | 522.93M 19.52% | 1.24B 136.96% | 1.07B 13.53% | 1.48B 38.13% | 4.11B 177.64% | 1.80B 56.31% | 609.06M 66.07% | 769.53B 126,248.09% | ||
net current asset value | -2.15M - | -16.76M 677.91% | -87.49M 421.90% | 92.61M 205.85% | 167.02M 80.35% | 190.55M 14.09% | 217.40M 14.09% | 240.07M 10.43% | 383.47M 59.73% | 203.11M 47.03% | 190.77M 6.08% | |
net debt to ebitda | 0.76 - | -0.78 203.04% | 1.54 298.11% | 0.95 38.60% | 0.90 4.83% | 1.48 64.23% | 0.84 43.19% | 0.92 8.91% | 0.43 52.91% | 0.57 31.66% | ||
net income per share | -0.89 - | -2.04 130.40% | -3.02 47.71% | -2.98 1.07% | -2.33 21.76% | -2.47 5.81% | -1.87 24.43% | -2.74 46.64% | -2.98 8.72% | -0.00 99.93% | ||
operating cash flow per share | -0.56 - | -0.15 73.00% | -1.55 923.84% | -0.23 84.93% | -0.97 315.56% | -0.81 16.16% | -3.07 277.13% | -2.42 21.06% | -2.58 6.62% | -0.00 99.93% | ||
payables turnover | ||||||||||||
receivables turnover | 1.60 - | 68.78 4,202.70% | 20.22 70.61% | 1.06K 5,165.45% | 49.12 95.39% | 15.00 69.46% | 95.67 537.72% | 3.83 96.00% | ||||
research and ddevelopement to revenue | 11.57 - | 9.41 18.63% | 6.06 35.65% | 2.84 53.14% | 4.72 66.27% | 1.74 63.10% | 5.58 220.38% | 8.88 59.09% | ||||
return on tangible assets | -1.12 - | -0.49 56.53% | -0.42 13.12% | -0.32 23.98% | -0.26 18.86% | -0.24 7.24% | -0.19 21.24% | -0.27 42.99% | -0.40 45.42% | -0.31 22.74% | ||
revenue per share | 0.05 - | 0.19 311.71% | 0.34 81.22% | 0.68 99.18% | 0.41 39.43% | 1.55 276.88% | 0.38 75.60% | 0.29 24.01% | ||||
roe | 0.89 - | 0.88 1.99% | -0.72 182.31% | -0.58 19.91% | -0.47 19.48% | -0.47 1.05% | -0.28 40.91% | -0.33 20.27% | -0.57 69.46% | -0.44 22.53% | ||
roic | 0.80 - | -0.15 118.23% | -0.45 206.37% | -0.42 5.74% | -0.35 16.29% | -0.41 15.23% | -0.29 29.69% | -0.31 7.35% | -0.47 52.46% | -0.36 22.28% | ||
sales general and administrative to revenue | 11.11 - | 7.64 31.20% | 3.68 51.87% | 1.72 53.18% | 3.14 82.55% | 0.74 76.31% | 2.98 300.44% | 3.59 20.27% | ||||
shareholders equity per share | -0.99 - | -2.33 135.08% | 4.18 279.45% | 5.16 23.52% | 5.01 2.83% | 5.25 4.71% | 6.72 27.90% | 8.19 21.92% | 5.25 35.85% | 0.00 99.91% | ||
stock based compensation to revenue | 2.16 - | 2.79 29.32% | 1.70 38.97% | 0.83 51.07% | 1.33 59.33% | 0.26 80.77% | 1.70 565.71% | 1.49 12.53% | ||||
tangible asset value | -1.76M - | -15.29M 767.39% | -83.11M 443.51% | 134.61M 261.95% | 208.08M 54.58% | 236.16M 13.50% | 262.44M 11.13% | 393.59M 49.97% | 553.64M 40.67% | 360.68M 34.85% | 349.10M 3.21% | |
tangible book value per share | -0.99 - | -2.33 135.08% | 4.18 279.45% | 5.16 23.52% | 5.01 2.83% | 5.25 4.71% | 6.72 27.90% | 8.19 21.92% | 5.25 35.85% | 0.00 99.91% | ||
working capital | -39K - | 4.55M 11,779.49% | 138.06M 2,930.95% | 154.10M 11.62% | 295.49M 91.75% | 338.88M 14.68% | 403.88M 19.18% | 360.88M 10.65% | 460.43M 27.58% | 296.64M 35.57% | 277.61M 6.42% |
All numbers in USD (except ratios and percentages)